Cabozantinib-Exposed Renal Cell Carcinoma Organoids Suggest Transcriptomic Associations With Treatment Resistance in Clear Cell and Nonclear Cell Tumors. jkcvhl 2025, 12 (2), 37-45. https://doi.org/10.15586/jkcvhl.v12i2.386.